Abstract
Dermatofibrosarcoma protuberans is an uncommon cutaneous tumour which rarely metastasises. However, local recurrence following apparently adequate surgical excision is well recognised, presumably as a result of sub-clinical contiguous growth, for which micrographically controlled excision would be a logical treatment. A retrospective study of all patients treated by micrographic surgery, from April 1995–March 2000, at a tertiary skin oncology centre. Twenty-one patients (11 males), age 14 to 71 years with dermatofibrosarcoma protuberans on the trunk (10 patients), groin (four), head and neck (four), and limbs (three) were treated. In 15 patients one micrographic layer cleared the tumour, and four were cleared with two layers. For one patient the second stage was completed by conventional excision guided by positive margins. Another patient with a multiply recurrent perineal dermatofibrosarcoma protuberans, not cleared in one area after two layers, died from a pulmonary embolus before total clearance could be achieved. There was no correlation between tumour size and lateral excision margin. No recurrence was observed during the follow-up, from 21 to 80 months, median 47 months. The study provides further support for micrographic surgery as the treatment of choice for dermatofibrosarcoma protuberans.
Main
Dermatofibrosarcoma protuberans (DFSP) is an uncommon fibrosarcoma which appears to originate from dermal fibroblasts (Taylor and Helwig, 1962; Lautier et al, 1990). It grows slowly and contiguously with wide extension between adjacent collagen bundles, and not infrequently into the underlying fascia and muscle. These microscopic infiltrations may not be clinically apparent, and can be missed on histology by using conventional serial vertical sections.
Regional and distant metastases from DFSP do occur but are rare, probably less than 1% (Smola et al, 1991), and certainly lower than previous estimates of 4–6% (Roses et al, 1986; Rutgers et al, 1992). Distant metastases to the lung, even up to 9 years after primary excision, have been described (Taylor and Helwig, 1962). The risk of metastasis appears to increase with repeated incomplete excision and de-differentiation towards a higher-grade fibrosarcoma (Taylor and Helwig, 1962). Fatalities from direct intra-cerebral invasion have also been reported (Mcpeak et al, 1967; Barnes and Coleman, 1984).
Treatment of DFSP by local excision consistently results in high recurrence rates of 30–76% (Taylor and Helwig, 1962; Mcpeak et al, 1967; Hajdu, 1979; Smola et al, 1991; Mark et al, 1993). The recommended approach has been wide local excision with lateral margins of at least 3 cm and including the underlying fascia (Mcpeak et al, 1967; Bendix-Hansen et al, 1983; Roses et al, 1986; Rutgers et al, 1992). Larger margins do produce better clearance rates but a corresponding greater loss of tissue as there is no reason to believe that the tumour growth is concentric with the clinical margin. A lateral margin of 3 cm results in a local recurrence rate of 10–20% (Mcpeak et al, 1967; Roses et al, 1986; Gloster et al, 1996) and at 4 cm a recurrence rate of 6% was found in 96 patients (Petoin et al, 1985). Of 58 cases, even a 10 cm excision width would not have cleared the tumour in two patients (Ratner et al, 1997).
The aim of treatment should be complete tumour clearance and maximum preservation of normal tissue. Micrographic controlled excision (MCE) of skin tumours allows examination of all surgical margins, and preliminary evidence for DFSP suggested this method to be effective (Mikhail and Lynn, 1978; Robinson, 1985; Parker and Zitelli, 1995). Results from subsequent series and retrospective studies show a consistently high rate for complete clearance in both primary and recurrent tumours (Hobbs et al, 1988; Dawes and Hanke, 1996; Gloster et al, 1996; Haycox et al, 1997; Ratner et al, 1997). Together these reports appear to indicate support for MCE as the most appropriate treatment of DFSP. We present the results of all our patients in support of MCE as the treatment of choice for DFSP.
Materials and methods
Clinical data
Diagnosis of DFSP was confirmed histologically and on positive CD34 staining by an experienced dermatohistopathologist (DSAS). Twenty-one patients with DFSP were treated by MCE, undertaken by one operator (JR Marsden), from April 1995 to March 2000. The following characteristics recorded include age at presentation, sex, duration of tumour, clinical size, site and any prior attempt at excision. Also details of inpatient or outpatient care, mode of anaesthesia used, number of micrographic stages, margin and depth of excision, type of repair, complications, cosmesis and functional outcome, were documented. Each subject was recalled for a final outpatient review to corroborate clinical information and update clinical outcome.
Operative method
The tumour or residual scar tissue was debulked prior to MCE. A modified Mohs micrographic surgical procedure which utilised formalin-fixed, paraffin embedded tissue for an improved interpretation of histology of soft-tissue tumours was employed (Clayton et al, 2000). Micrographic layers of 2–3 mm thick were excised to give an initial 1 cm lateral excision margin from the tumour or scar margin, except in one patient where the initial margin was 0.5 cm. The first layer was resected down to the deep fascia. Guided by histologically positive margins, subsequent micrographic layers were excised at 1 cm intervals to minimise the total number of resection stages. These were divided, colour-coded, orientated in tissue cassettes, fixed and embedded in paraffin before staining with haematoxylin and eosin, and for CD34. Sections were reported within 20 h, if necessary further MCE was performed within 24 h until clearance. Analysis for statistical correlation between tumour diameter and lateral excision was undertaken by Minitab statistical package.
Results
Clinical characteristics
Of the 21 patients, 11 were male, and the age at presentation 36 (14–71) years, median (range). The duration of onset to presentation was 24 months (6 months to 30 years). Maximum tumour diameter was 3.25 (1.5–16) cm. Clinically, most were typical indurated rubbery pale brown/pink plaques with a smooth surface and often studded with multiple nodules. The sites of presentation were the trunk (10 patients), groin (four), head and neck (four), and limbs (three). The commonest site was upper chest (seven patients).
Most patients were referred with a primary DFSP, however five patients presented with recurrent tumours. Of these three recurred within 18 months of the initial local excision, one had re-grown slowly over the site of an incompletely excised DFSP 20 years previously, and another had a repeatedly recurrent perineal tumour treated unsuccessfully by wide local excision on at least three occasions over 15 years. Eleven were referred from their primary care physician, the majority of whom had not yet had a histological diagnosis. The other patients were sent after a diagnosis had been established on histology. Seven patients had undergone previous resection of the primary tumour which were histologically incompletely excised, and at tertiary consultation showed no visible or palpable tumour.
Results of micrographic surgery
To achieve the clearance of tumour in 21 patients, 15 required only one micrographic layer, and four needed a second layer. In two other patients, however, total clearance could not be assessed. One had extensive sub-clinical involvement in six out of nine micrographic samples over both lateral and deep margins after the first micrographic layer. Further surgery under local anaesthesia was not possible due to the extent of the lesion and its complex site in the supraclavicular fossa and root of neck. The second excision layer was directed by histologically positive margins, but carried out conventionally. In the other patient a large multiply recurrent perineal DFSP was not cleared in the deep margin after the second micrographic layer. Unfortunately, he died on the 10th post-operative day from a pulmonary embolus before further micrographic surgery could be undertaken.
Of those cleared after a second layer, two patients required a micrographic layer to both lateral and deep margins, and in the other two further layers to the deep margin only. Further resection to the deep margin involved partial excision of the sternomastoid muscle, full thickness dartos muscle, rectus sheath and full-thickness occipital bone. With the addition of the lateral margin from a prior excision biopsy, measuring 0.5–1.5 cm, recorded in three patients, the total margin of lateral clearance ranged from 0.5 to a maximum of 2.5 cm, median 1.5 cm. This corresponds to a clearance of 0.5 cm in one patient (5%), 1 cm in 12 patients (56%), 1.5 cm for four (19%), 2 cm in one (5%), and 2.5 cm in another (5%). In our cohort, there was no significant statistical correlation evident between maximal tumour size and lateral margin necessary for complete excision (Spearman rank correlation=0.043; P=0.854, n=21) (Figure 1). For the first micrographic layer, a median of 12 samples were processed, range four to 76, and in the second layer, a median of six samples, range two to 15.
Sixteen patients were treated under local anaesthesia, five needed regional or general anaesthesia which included the youngest or those with the largest tumours. Twelve were managed as outpatient cases in the day surgical unit, and nine patients required further in-patient care, admission duration 2 (1–10) days, including those who had general anaesthesia.
For 15 patients the surgical defects were closed directly. Four required split skin grafts, one to an overlying pectoralis muscle flap. A patient needed a cavarial graft followed by a scalp rotation flap. Except for the fatality which occurred despite prophylaxis for deep vein thrombosis, the only other early post-operative complication was transient flexion weakness and paraesthesia of the fingers developing distal to the surgical site. At follow-up cosmesis was assessed by the attending physician. In 16 patients the wound cosmesis was described as very good, four as fair compromised by split skin grafts, stretched scars and in another a hypertrophied scar treated satisfactorily with intra-lesional triamcinolone. No permanent functional deficit was noted. There was no recurrence observed during the follow-up interval 47 (21–80) months.
Discussion
DFSP represents about 1% of all soft tissue sarcomas with an estimated incidence of 0.8/million (Bendix-Hansen et al, 1983). A higher standardised incidence rate of 4.5/million from 1970 to 1984, based on crude rates of four female cases was reported in the Rochester population (Tsu et al, 1990). In comparison, age standardised incidence data from the West Midlands Cancer Intelligence Unit showed a mean annual rate of 1.8/million for the region between the period 1984 to 1998 (personal communication, Dr Cheryl Hyde) on a crude rate of 142 histologically confirmed cases. Over the corresponding period, we estimate an age standardised incidence of 2.1/million for males and 1.5/million for females, which confirms the previously suggested male predominance in several case series (Pack and Tabah, 1951: Taylor and Helwig, 1962; Mcpeak et al, 1967).
The median age at presentation of 36 years is comparable to other reports which observed onset from the third to fifth decade (Taylor and Helwig, 1962; Mcpeak et al, 1967). As expected, the time to presentation extends from weeks to decades but was usually several years (Mcpeak et al, 1967). The tumour has been described on almost every site on the body surface, typically as an indurated dermal and subcutaneous plaque or nodule. Consistent with previous observations the commonest area in half of all cases was the upper trunk, especially the supra-clavicular fossa (Pack and Tabah, 1951; Taylor and Helwig, 1962; Mcpeak et al, 1967, Roses et al, 1986; Hajdu, 1979). There are reports describing a history of trauma in 10–20% of cases preceding the development of DFSP (Pack and Tabah, 1951; Taylor and Helwig, 1962). In one of our patients the tumour developed within an old burn scar, and another after a scarring spade injury to his shoulder.
In our study, all the tumours could be completely resected with 2.5 cm lateral margins, but this does not include four out of seven patients who had a prior diagnostic excision biopsy where the lateral margins were not recorded. Other studies of Mohs micrographic excision for DFSP showed a comparable clearance rate for lateral margins (Table 1).
Tumour extension into the deep fascia is a common finding and is associated with recurrence. In a series of 20 patients all tumours were cleared by micrographic excision of deep fascia and superficial muscle layer, with those over the forehead and scalp through the periosteum (Parker and Zitelli, 1995). Of 10 patients treated by micrographic surgery, four had invaded muscle of whom two had periosteum involvement (Hobbs et al, 1988). In four cases described by Robinson, two had extended into superficial muscle and the others localised in fascia (Robinson, 1985). Excision of fascia were undertaken in six out of 16 (27%) where the tumour recurred, compared to 23 (72%) out of 32 in whom tumour did not recur (Roses et al, 1986).
We found no statistical relationship between tumour size and required margin of excision but four patients had prior unrecorded excision biopsy margins. Similarly, in those five patients with recurrent tumours, the size would be underestimated by preceding attempts at clearance. Other studies have not observed a relationship of maximum tumour size to excision margin (Roses et al, 1986; Ratner et al, 1997). However, one report found tumours less than 2 cm could be safely excised by a 1.5 cm lateral margin (n=9), as opposed to those greater than 2 cm which needed 2.5 cm margin (n=11) (Parker and Zitelli, 1995). Although in this study eight were recurrent tumours, and the number who had a prior diagnostic biopsy were not specified.
To date no recurrence of DFSP following micrographically controlled excision have been observed after a follow-up interval of 38 (12–71) months in our series. From previous studies of conventional local excision, the majority of recurrences developed early after resection. Approximately half presented within 2 years, and 80% within 3 years (Mcpeak et al, 1967). Of 20 patients six recurred at 21 (6–36) months for lateral margins of 1–3 cm (Smola et al, 1991). In 98 cases, a 49% recurrence was observed after local resection; 40% within the first year, and 75% in the first 3 years (Taylor and Helwig, 1962). Similar recurrence rates were found by McPeak in 82 patients, and a series of 119 patients treated by wide excision (Mcpeak et al, 1967; Hajdu, 1979). The head and neck is a more common site for recurrence, and it is unclear whether this reflects the difficulties in excising DFSP over this area (Barnes and Coleman, 1984; Mark et al, 1993). A small number of patients, however, present with a very delayed recurrence, up to 20 years after excision (Mcpeak et al, 1967; Mikhail and Lynn, 1978; Roses et al, 1986). Of our group, one patient presented with a DFSP on her forehead, at the site of a previously suspected DFSP excised over 20 years earlier.
The current evidence to support MCE for the treatment of DFSP derives from case observations and retrospective studies (Dawes and Hanke, 1996; Haycox et al, 1997). The largest study incorporates grouped data of 50 patients from several centres (Ratner et al, 1997). Haycox et al (1997) reviewed the world-wide literature and found a mean recurrence rate of 2.4% from a total of 169 reported cases. Although most series describe no recurrences the highest reported rate was two out of 24 cases (8.3%) (Dawes and Hanke, 1996), with two other groups each having had one recurrence in 15 (6.6%) and 50 (2%) patients followed-up (Gloster et al, 1996; Ratner et al, 1997).
Recent retrospective series have revealed promising results for adjuvant radiotherapy in preventing local recurrence of incompletely excised DFSP but its role yet remains to be established (Haas et al, 1997; Linder et al, 1999).
For day surgery under local anaesthetic, an estimated cost of wide local excision at £460 compared well with one stage of MCE at £560, the only treatment required in 12 patients. Of the nine patients who required overnight stay after MCE the total cost for each was estimated at £1770 per day inclusive of general anaesthesia. The operative time is not any longer for MCE but processing the specimen takes 10–25 min per micrographic layer. Histopathology reporting of micrographic sections is considerably more demanding, from five to 10 times longer than conventional sections, depending on the number of samples. The higher cost of MCE, however, would be outweighed by the improved surgical outcome and prognosis.
In summary, our data provides further support for the favourable outcome following margin control in the excision of DFSP. This approach demonstrates very low recurrence rate with optimum conservation of normal tissue, and would be the treatment of choice for DFSP.
Acknowlegements
We are grateful to Dr Cheryl Hyde of the West Midlands Cancer Intelligence Unit, Public Health Building, The University of Birmingham, Birmingham, for providing the incidence data. We would like to acknowledge the help of Mr RA Walsh, consultant surgeon, department of neurosurgery, Queen Elizabeth Hospital, and Mr S Dover, consultant surgeon, department of maxillo-facial surgery, Queen Elizabeth Hospital, for their clinical support.
References
Barnes L, Coleman JA (1984) Dermatofibrosarcoma protuberans of the head and neck. Arch Otolaryngol 110: 398–404
Bendix-Hansen K, Myhre-Jensen O, Kaae S (1983) Dermatofibrosarcoma protuberans: a clinic-pathological study of nineteen cases and review of world literature. Scand J Plast Reconstr Surg 17: 247–252
Clayton BD, Leshin B, Hitchcock MG, Marks M, White WL (2000) Utility of rush paraffin-embedded tangential sections in the management of cutaneous neoplasms. Dermatol Surg 26: 671–678
Dawes KW, Hanke CW (1996) Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins. Dermatol Surg 22: 530–534
Gloster HM, Harris KR, Roenigk RK (1996) A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 35: 82–87
Haas RL, Keus RB, Loftus BM, Rutgers EJ, van Coevorden F, Bartelink H (1997) The role of radiotherapy in the local management of dermatofibrosarcoma protuberans. Soft Tissue Tumours Working Group. Eur J Cancer 33: 1055–1060
Hajdu SI (1979) Tumors of Fibrous Tissue. In Pathology of soft tissues pp 82–94, Philadelphia: Lea & Febiger
Haycox CL, Odland PB, Olbricht SM, Casey B (1997) Dermatofibrosarcoma protuberans (DFSP): growth characteristics based on tumour modeling and a review of cases treated with Mohs micrographic surgery. Ann Plast Surg 38: 246–251
Hobbs ER, Wheeland RG, Bailin PL, Ratz JL, Yetman RJ, Zins JE (1988) Treatment of dermatofibrosarcoma protuberans with Mohs micrographic surgery. Ann Surg 207: 1027
Lautier R, Wolf HH, Jones RE (1990) An immunohistochemical analysis of dermatofibrosarcoma protuberans supports its fibroblastic character and contradicts neuroectodermal or histiocytic components. Am J Dermatopath 12: 25–30
Linder NJ, Scarborough MT, Powell GJ, Spandier S, Enneking WF (1999) Revision surgeryin dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol 25: 392–397
McPeak CJ, Cruz T, Nicastri AD (1967) Dermatofibrosarcoma protruberans: an analysis of 86 cases, five with metastases. Ann Surg 166: 803–816
Mark RJ, Bailet JW, Tran LM, Poen J, Fu YS, Calcaterrra TC (1993) Dermatofibrosarcoma protuberans of the head and neck. Arch Otolaryngol Head Neck Surg 119: 891–896
Mikhail GR, Lynn BH (1978) Dermatofibrosarcoma protuberans. J Dermatol Surg Oncol 4: 81–84
Pack GT, Tabah EJ (1951) Dermatofibrosarcoma protuberans. A report of thirty-nine cases. Arch Surg 63: 391–411
Parker TL, Zitelli JA (1995) Surgical margins for the excision of dermatofibroma-sarcoma protuberans. J Am Acad Dermatol 32: 233–236
Petoin DS, Verola O, Banzet P, Dufourmentel C, Servant JM (1985) Darier-Ferrand dermatofibrosarcoma: study of 96 cases over 15 years. Chirurgie 111: 132–138
Ratner D, Thomas CO, Johnson TM, Sondak VK, Hamilton TA, Nelson BR, Swanson NA, Garcia C, Clark RE, Grande DJ (1997) Mohs micrographic surgery for the treatment of dermatofibrobosarcoma protuberans. J Am Acad Dermatol 37: 600–613
Robinson JK (1985) Dermatofibromasarcoma protuberans resected by Mohs's surgery (chemosurgery). J Am Acad Dermatol 12: 1093–1098
Roses DF, Valensi Q, La Trenta G, Harris MN (1986) Surgical treatment of dermatofibrosarcoma protruberans. Surg Gynecol Obstet 162: 449–452
Rutgers EJ, Kroon BB, Albus-Lutter CE, Gortzak E (1992) Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol 18: 241–248
Smola MG, Soyer HP, Scharnagel E (1991) Surgical treatment of dermatofibrosarcoma protruberans. A retrospective study of 20 cases with review of literature. Eur J Surg Oncol 17: 447–453
Taylor HB, Helwig EB (1962) Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 15: 717–725
Tsu YC, Su D, Muller SA (1990) Incidence of cutaneous T cell lymphoma and other rare skin cancer in a defined population. J Am Acad Dermatol 23: 254–256
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ah-Weng, A., Marsden, J., Sanders, D. et al. Dermatofibrosarcoma protuberans treated by micrographic surgery. Br J Cancer 87, 1386–1389 (2002). https://doi.org/10.1038/sj.bjc.6600643
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600643
Keywords
This article is cited by
-
Dermatofibrosarcoma protuberans challenges: a case series and review of the literature
Journal of Medical Case Reports (2023)
-
Management of Recurrent Dermatofibro Sarcoma Protuberance of Scalp-a Reconstructive Challenge
Indian Journal of Surgical Oncology (2013)
-
Current treatment options in dermatofibrosarcoma protuberans
Journal of Cancer Research and Clinical Oncology (2009)
-
Management of sarcomas of the head and neck
Current Oncology Reports (2004)